Table 1. Clinicopathologic characteristics of 90 young patients with MAC and SRC.
Variable | Value | Percentage |
---|---|---|
Median age (range), y | 36 (20–40) | - |
Gender, n | ||
Male | 69 | 77% |
Female | 21 | 23% |
Primary tumor location, n | ||
Colon | 48 | 53.3% |
Rectum | 42 | 46.7% |
Histologic types, n | ||
MAC | 69 | 77% |
SRC | 21 | 23% |
Adjuvant CT | ||
Yes | 83 | 92.2% |
No | 7 | 7.8% |
Cycles of adjuvant CT, n | ||
≥6 | 76 | 84.4% |
<6 | 14 | 15.6% |
Tumor size, cm | ||
≥5 | 45 | 50% |
<5 | 45 | 50% |
Surgical type, n | ||
Radical | 65 | 72.2% |
Palliative | 25 | 17.8% |
T stage, n | ||
T1/T2 | 4 | 4.4% |
T3/T4 | 86 | 85.6% |
N stage, n | ||
N0 | 23 | 25.6% |
N1 | 30 | 33.3% |
N2 | 37 | 41.1% |
Metastasis, n | ||
No | 69 | 76.7% |
Yes | 21 | 23.3% |
Stage, n | ||
I/II | 15 | 16.7% |
III/IV | 75 | 83.3% |
Preoperative CEA levels | ||
Mean (range), U/ml | 18.5 (0.2–279) | - |
Lymphovascular invasion, n | ||
Positive | 41 | 45.6% |
Negative | 49 | 54.4% |
Perineural invasion, n | ||
Positive | 40 | 44.4% |
Negative | 50 | 55.6% |
Abbreviations: n, number; y, year.